| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 12/20/2006 | CN1879817A Medicine for treating Bi syndrome and method for preparing same |
| 12/20/2006 | CN1879801A An externally applied Chinese medicinal bag for relieving pain |
| 12/20/2006 | CN1879777A Blood circulation-invigorating tendon-strengthening preparation and method for preparing same |
| 12/20/2006 | CN1879772A Wind-expelling cold-clearing Dog skin plaster |
| 12/20/2006 | CN1879766A Medicine for treating rheumatism and preparation method thereof |
| 12/20/2006 | CN1879762A Wind-expelling pain-relieving liquid and method for preparing same |
| 12/20/2006 | CN1879750A Liver tonic and novel preparation method thereof |
| 12/20/2006 | CN1879749A Medicinal heath wine |
| 12/20/2006 | CN1879743A Oral liquid of litchi seed and method for making same |
| 12/20/2006 | CN1879723A Meridian obstruction dredging pills |
| 12/20/2006 | CN1879722A A medicine for treating rheumatic arthritis |
| 12/20/2006 | CN1879721A A compound capsule for treating Bi syndrome |
| 12/20/2006 | CN1879678A Medicinal pills for treating rheumatism |
| 12/20/2006 | CN1879670A Toxin-lifting pain-easing ointment |
| 12/20/2006 | CN1879665A Quickly-acting defervescence plaster used for infants and preparation method thereof |
| 12/20/2006 | CN1879660A A method for preparing novel chemical substance with anti-fertility and pain relieving activity |
| 12/20/2006 | CN1879653A Bezoar nano-powder preparation process and pharmaceutical preparation thereof |
| 12/20/2006 | CN1879652A Dried material and method for the manufacture thererof |
| 12/20/2006 | CN1879644A Use of actiin in preparation of anti-inflammatory drug |
| 12/20/2006 | CN1879629A Estrogen replacement therapy |
| 12/20/2006 | CN1879619A Cancer treatment |
| 12/20/2006 | CN1879618A Compound paracetamol injection for animal and preparation method thereof |
| 12/20/2006 | CN1879617A Modulating multiple lineage kinase proteins |
| 12/20/2006 | CN1290842C Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor |
| 12/20/2006 | CN1290567C Medicine for treating cold and pain of abdomen before and during menstruation and its preparation method |
| 12/20/2006 | CN1290561C Chinese medicinal composition for treating respiratory illness and digestive illness |
| 12/20/2006 | CN1290551C Combination of Chinese traditional medicine in use for invigorating the kidney and strengthening bone |
| 12/20/2006 | CN1290550C Chinese medicine composition for treating rheumatism, rheumatoid, hyperosteogeny and fracture and preparing method thereof |
| 12/20/2006 | CN1290548C Traditional Chinese medicine for treating bone fracture and rheumatic diseases |
| 12/20/2006 | CN1290542C Chinese medicinal composition for treating ankylosing spondylitis |
| 12/20/2006 | CN1290501C Pharmaceutically active isoindoline derivatives |
| 12/20/2006 | CN1290494C Externally applied long-acting analgesic |
| 12/19/2006 | USRE39433 Therapeutic agents as cytokine antagonists and agonists |
| 12/19/2006 | US7151175 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 12/19/2006 | US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma |
| 12/19/2006 | US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 12/19/2006 | US7151109 Psychological disorders; anxiolytic agents; antidepressants |
| 12/19/2006 | US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases |
| 12/19/2006 | US7151098 Glutamate receptor antagonists |
| 12/19/2006 | US7151095 Oral and rectal drug delivery of a mixture of 4-aminophenylacetic acid and 5-aminosalicylic acid; antiinflammatory agents for gastrointestinal tract; antiulcer agents; bis(sodium carboxyl phenyl)azo compounds |
| 12/19/2006 | US7150983 Modified proteolytic enzyme for treatment of osteoarthritis |
| 12/19/2006 | CA2264979C Dicyclic-aromatic compounds and their application in human and veterinary medicine, as well as in cosmetics |
| 12/19/2006 | CA2194761C Immunomodulatory oligonucleotides |
| 12/19/2006 | CA2159091C Topical and systemic application of buspirone or derivatives thereof for treatment of pathological conditions associated with immune responses |
| 12/14/2006 | WO2006133459A1 Indane derivatives as modulators of ion channels |
| 12/14/2006 | WO2006133286A2 Treatment of tnf antagonist-resistant inflammatory disorders and related methods |
| 12/14/2006 | WO2006132442A1 Vitamin d-like compound |
| 12/14/2006 | WO2006132438A1 1,3-benzothiazinone derivative and use thereof |
| 12/14/2006 | WO2006132295A1 Regulator of aldosterone receptor |
| 12/14/2006 | WO2006132261A1 Therapeutic agent and/or prophylactic agent for neurogenic pain |
| 12/14/2006 | WO2006132205A1 Radical scavenger and active oxygen eliminating agent |
| 12/14/2006 | WO2006132204A1 Transcription factor decoy |
| 12/14/2006 | WO2006131737A2 Method and composition for treating inflammatory disorders |
| 12/14/2006 | WO2006131296A1 Substituted n-benzo [d] isoxazol-3-yl-amine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 12/14/2006 | WO2006131200A1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
| 12/14/2006 | WO2006131186A1 Oxindoles as kinase inhibitors |
| 12/14/2006 | WO2006131013A2 STABLE AND SOLUBLE ANTIBODIES INHIBITING TNFα |
| 12/14/2006 | WO2006113981A3 Process to obtain dibenzylbutyrolactonic, tetrahydrofuranic lignans and their synthetic and semi-synthetic derivatives, their analgesic and anti-inflammatory activities, topical and/or systemic formulations containing said lignans and their respective therapeutic method |
| 12/14/2006 | WO2006110884A8 2, 6-di (hetero) aryl -4-amido-pyrimidines as adenosine receptor antagonists |
| 12/14/2006 | WO2006101977A3 Pyrimidine compounds and methods of use |
| 12/14/2006 | WO2006084017A3 Phenyl-substituted pyrimidine compounds useful as kinase inhibitors |
| 12/14/2006 | WO2006053766A8 Methods for purifying trans-(-)-δ9-tetrahydrocannabinol and trans-(+)-δ9-tetrahydrocannabinol |
| 12/14/2006 | US20060281926 Synthesis of 2-alkylcysteine via phase transfer catalysis |
| 12/14/2006 | US20060281887 (Meth)acrylate copolymer for use as medical carrier |
| 12/14/2006 | US20060281798 Methods of using thiazolidinedithione derivatives |
| 12/14/2006 | US20060281742 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof |
| 12/14/2006 | US20060281734 3-[5-(3-acetamidobenzamido)-2-methylphenyl]-6-(4-methylpiperazin-1-yl)-3,4-dihydroquinazolin-4-one for example; treating rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease; inhibitor of cytokine-mediated disease |
| 12/14/2006 | US20060281733 4-Bromo-5-(2-chloro-benzoylamino)-1H-pyrazole-3-carboxylic acid (2-pyrrolidin-1-yl-ethyl)-amide; 5-(2-chlorobenzoylamino)-1H-pyrazole-3-carboxylic acid {2-[4-(4,5-dihydro-1H-imidazol-2-yl)-phenyl]ethyl}amide; useful for the moderation of pain, septic shock, and scarring |
| 12/14/2006 | US20060281726 Piperidine derivatives for the treatment of chemokine or h1 mediated disease state |
| 12/14/2006 | US20060281719 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 12/14/2006 | US20060281716 Alkaloid formulations |
| 12/14/2006 | US20060281704 Regulation of endogenous gene expression in cells using zinc finger proteins |
| 12/14/2006 | US20060280820 Use of an extract of Aloysia/Verbena/Lippia triphylla/citriodora for the treatment of chronic and/or inflammatory diseases |
| 12/14/2006 | US20060280811 Formulations for the treatment of arthritis conditions |
| 12/14/2006 | US20060280794 Solid pharmaceutical preparation |
| 12/14/2006 | US20060280692 A condensation aerosol for delivery of olanzapine by heating a compositionof olanzapine coated on a solid support to vaporize and condense; the vapor comprising particles of >10 percent by weight of olanzapine and <5 percent by weight of olanzapine degradation products; aerodynamic diameter=<5 microns |
| 12/14/2006 | DE102005009194B4 Verfahren zur Herstellung von polymorph stabilem Triamcinolonacetonid A process for producing polymorphic stable triamcinolone acetonide |
| 12/14/2006 | CA2614295A1 Transcription factor decoy |
| 12/14/2006 | CA2611731A1 Indane derivatives as modulators of ion channels |
| 12/14/2006 | CA2611401A1 Oxindoles as kinase inhibitors |
| 12/14/2006 | CA2610986A1 Agent for treating and/or preventing neuropathic pain |
| 12/14/2006 | CA2610800A1 2,6 quinolinyl derivatives, processes for preparing them and their use as medicament |
| 12/14/2006 | CA2610373A1 Substituted n-benzo [d] isoxazol-3-ylamine derivatives as inhibitors of mglur5, serotonine (5-ht) and noradrenaline receptors, and the use thereof for producing medicaments |
| 12/14/2006 | CA2609999A1 Stable and soluble antibodies inhibiting tnfalpha |
| 12/14/2006 | CA2608631A1 Method and composition for treating inflammatory disorders |
| 12/13/2006 | EP1731608A1 Marker gene for arthrorheumatism test |
| 12/13/2006 | EP1731516A2 The 9,11-cycloendoperoxide prodrugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 12/13/2006 | EP1731161A1 Compositions for the treatment of diseases associated with elevated sphingolipid concentrations |
| 12/13/2006 | EP1731152A2 Sustained analgesia achieved with transdermal delivery of buprenorphine |
| 12/13/2006 | EP1731150A1 Niosome having metal porphyrin complex embedded therein, process for producing the same and drug with the use thereof |
| 12/13/2006 | EP1731139A1 S/o type pharmaceutical preparation and process for producing the same |
| 12/13/2006 | EP1730145A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics |
| 12/13/2006 | EP1729771A1 Pyridyl derivatives and their use as mglu5 receptor antagonists |
| 12/13/2006 | EP1729747A2 Thiol reactive agents as a therapeutic modality |
| 12/13/2006 | EP1596856B1 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
| 12/13/2006 | EP1501523A4 Carbon monoxide as a biomarker and therapeutic agent |
| 12/13/2006 | EP1436877B1 An intelligent serial battery charger and charging block |
| 12/13/2006 | EP1434790B1 Calcium-influx inhibitory factor and method of isolation thereof |
| 12/13/2006 | EP1425014B1 Diaryl cycloalkyl derivatives, method for producing the same and the use thereof as ppar activators |
| 12/13/2006 | EP1328252B1 Transdermal pharmaceutical delivery composition |